COMPOSITIONS, METHODS, AND USES FOR POLYNUCLEOTIDE FORMULATIONS FOR DRYING AND PROLONGED STORAGE

METHODS FOR THE PROPHYLAXIS AND TREATMENT OF COVID AND COVID-19

SALMONELLA FREE EGG PRODUCTION METHODS AND SYSTEMS

NOVEL REOVIRUS-BASED VACCINE PLATFORM AND USE THEREOF

SAPONIN-BASED ADJUVANTS AND VACCINES

Combination Treatment

MULTI-CBV VACCINE FOR PREVENTING OR TREATING TYPE I DIABETES

CONSTRUCTS, USE AND METHODS THEREOF

ATTENUATED VIRUSES USEFUL FOR VACCINES

IMMUNOGENIC COMPOSITION CONTAINING AN ANTIGEN AND AN ADJUVANT COMPRISING AL-MOFS

Liquid six combined vaccine composition

Vaccine Product

DIFFERENTIAL COATING OF MICROPROJECTIONS AND MICRONEEDLES ON ARRAYS

VACCINATION AGAINST CORONAVIRUS WITH POLIOMYELITIS VACCINE

VACCINE FORMULATIONS WITH INCREASED STABILITY

Methods for the prophylaxis and treatment of COVID and COVID-19

IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE

COMPOSITIONS OF ALUM NANOPARTICLES FOR IMMUNOMODULATION AND METHODS FOR PRODUCING THE SAME

ACTIVE BOOSTER IMMUNIZATION AGAINST TETANUS, DIPHTHERIA AND PERTUSSIS

METHOD AND COMPOSITION FOR ENHANCING THE IMMUNE RESPONSE

NEWCASTLE DISEASE VIRUS-BASED VECTORED VACCINE

TREATMENT FOR PRIMARY AND METASTATIC CANCER

ATTENUATED VIRUSES USEFUL FOR VACCINES

FILM WITH LATERALLY ADJOINED STRIPS FOR ADMINISTRATION OF A VACCINE

VACCINATION AGAINST CORONAVIRUS WITH POLIOMYELITIS VACCINE

Methods for Inducing a Safe Immune Response Against Polio Virus

IMMUNOGENIC COMPOSITIONS

Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same

VACCINATION AGAINST CORONAVIRUS WITH POLIOMYELITIS VACCINE

METHOD AND COMPOSITION FOR AMELIORATING AND ABATING SYMPTOMS RESULTING FROM RHEUMATOID ARTHRITIS, FIBROMYALGIA, AND CHRONIC PAIN OF UNKNOWN ORIGIN

COMPOSITION AND METHOD FOR STABILISING VACCINES IN A SOLID DOSAGE FORMAT

Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer

Multi-CBV vaccine for preventing or treating type I diabetes

NON-PSYCHOACTIVE CANNABINOIDS AS ADJUVANTS TO ENHANCE MUCOSAL IMMUNITY

METHOD AND COMPOSITION FOR STIMULATING IMMUNE RESPONSE

compositions and methods thereof

Methods for predicting tumor response to immunotherapy

Multi-CBV vaccine for preventing or treating type 1 diabetes

Process for enterovirus purification and inactivation and vaccine compositions obtained thereof

Combination Treatment

DIFFERENTIAL COATING OF MICROPROJECTIONS AND MICRONEEDLES ON ARRAYS

Immunogenic composition having improved stability, enhanced immunogenicity and reduced reactogenicity and process for preparation thereof

NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

COMPOSITIONS AND METHODS FOR PRODUCTION OF COLD-CHAIN VACCINES

ANTIGENIC THERMOSTABLE POLIO VACCINES & RELATED METHODS

Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof

CATIONIC NANOPARTICLES FOR ENHANCING INFECTIOUS CAPACITY OF LIVE VIRUSES

Multi-CBV vaccine for preventing or treating type I diabetes

NEWCASTLE DISEASE VIRUS-BASED VECTORED VACCINE

Poliovaccine

Malaria vaccine

IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE

VACCINE FORMULATIONS WITH INCREASED STABILITY

CHIMERIC ENTEROVIRUS VIRUS-LIKE PARTICLES

Multi-CBV vaccine for preventing or treating type I diabetes

METHOD AND COMPOSITION FOR AMELIORATING AND ABATING SYMPTOMS RESULTING FROM RHEUMATOID ARTHRITIS, FIBROMYALGIA, AND CHRONIC PAIN OF UNKNOWN ORIGIN

Multivalent vaccine composition

N-antigenic form poliovirus virus-like particles comprising thermostable mutations

Picornavirus-like particle production in plants

Recombinant HCMV and RHCMV vectors and uses thereof

Attenuated viruses useful for vaccines

Combination treatment

Antigens and vaccines directed against human enteroviruses

Antigens and vaccines directed against human enteroviruses

Adjuvanted formulations of booster vaccines

Immunogenic composition

Methods and compositions for stabilizing dried biological materials

compositions and methods thereof

METHOD FOR AMELIORATING AND ABATING SYMPTOMS RESULTING FROM RHEUMATOID ARTHRITIS, FIBROMYALGIA, AND CHRONIC PAIN OF UNKNOWN ORIGIN

Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof

Multi-CBV vaccine for preventing or treating type I diabetes

Adjuvant for mucosal vaccine

LASER ADJUVANTS FOR ENHANCING IMMUNE RESPONSE

Cell lines for virus production and methods of use

Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject

Methods of making modified viral genomes

Peptide/β-1,3-glucan complex and production method thereof and pharmaceutical composition containing peptide/β-1,3-glucan complex

Adjuvanted formulations of booster vaccines

Nasal mucosal vaccine composition

Adsorption of immunopotentiators to insoluble metal salts

Mucosal vaccine composition

Mucosal vaccine composition

Methods of immunization with varicella zoster virus antigen

COMBINATION IMMUNOGENIC COMPOSITIONS

Methods for the prevention of aggregation of viral components

ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

Recombinant HCMV and RHCMV vectors and uses thereof

CELL LINES FOR VIRUS PRODUCTION AND METHODS OF USE

Immunogenic compositions comprising silicified virus and methods of use

CONJUGATES FOR PROTECTING AGAINST DIPHTHERIA AND/OR TETANUS

VACCINE

NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

Picornavirus-like particle production in plants

Immunogenic composition

Immunogenic compositions

Antigens and vaccines directed against human enteroviruses

ADJUVANTED FORMULATIONS OF PEDIATRIC ANTIGENS

compositions and methods thereof

Adjuvant formulations and methods

Methods and compositions for stabilizing dried biological materials

MANUFACTURE OF VACCINES THAT CONTAIN BOTH HEPATITIS B VIRUS SURFACE ANTIGEN AND SURFACTANT

Production of poliovirus at high titers for vaccine production

LIQUID VACCINE PREPARATIONS

Hypo- and hyper-acetylated meningococcal capsular saccharides

DRY POWDER FORMULATIONS OF ORGANIC MACROMOLECULES

Methods of improving vaccine immunogenicity

Vaccination method employing genetically stable attenuated polioviruses comprising multiple mutations in domain V of the 5′ noncoding region

VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE

PROCESS FOR PRODUCING AN IMMUNOGENIC COMPOSITION CONTAINING TETANUS TOXOID

Inactivated poliovaccine

Drug transporter permeating blood-brain barrier, peptide and use thereof

VACCINE COMPOSITION

Recombinant HCMV and RHCMV vectors and uses thereof

ADJUVANTED VACCINES FOR SEROGROUP B MENINGOCOCCUS

PRODUCTION OF POLIOVIRUS AT HIGH TITERS FOR VACCINE PRODUCTION

Vaccine composition

Formulation of immunopotentiators

Manufacture of vaccines that contain both hepatitis B virus surface antigens and surfactant

MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH NON-HIB VACCINES

Vaccine Composition

Combination vaccine with acellular pertussis

COMBINATION VACCINE WITH WHOLE CELL PERTUSSIS

Drying process

Production of poliovirus at high titers for vaccine production

PROCESS FOR TREATMENT OF RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

Vaccine Against Streptococcus Pneumoniae

PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS, NON-VIRAL BASED CANCERS, ALZHEIMERS'S DISEASE, MUSCULAR DYSTROPHY, ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER, COMPLEX REGIONAL PAIN SYNDROME, DIABETES, NEUROPATHIC PAIN, SPIDER ARTHRITIS, WEST NILE VIRUS, FIBROMYALGIA, SHINGLES, GOUT, MIGRAINE HEADACHES, SENILE DEMENTIA, POST POLIO SYNDROME, CENTRAL VIRUS DEAFNESS, ASTHMA, CHRONIC PAIN OF UNKNOWN ORIGIN AND HEPATITIS C

COMBINATION VACCINES WITH 1-HYDROXY-2-PHENOXYETHANE PRESERVATIVE

Attenuated viruses useful for vaccines

Genetically stable attenuated polioviruses comprising multiple mutations in domain V of the 5′ noncoding region

MANUFACTURE OF BOOSTER VACCINES HAVING REDUCED ANTIGEN DOSES

Organic Compounds

ATTENUATED VIRUSES, VACCINES AND METHODS OF USE THEREOF

Hypo- and Hyper- Acetylated Meningococcal Capsular Saccharides

PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

Inactivated polio vaccines

Vaccine

IPV-DPT vaccine

VERO CELL LINE WHICH IS ADAPTED TO GROW IN SUSPENSION

Manufacture of Vaccines That Contain Both Hepatitis B Virus Surface Antigen and Surfactant

Chimeric lyssavirus nucleic acids and polypeptides

Inactivated Poliomyelitis Vaccine Derived From Sabin Strain Of Polio Virus

VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE

VACCINE COMPOSITION

Vaccine Comprising a Polysaccharide Antigen-Carrier Protein Conjugate and Free Carrier Protein

Vero cell line adapted to grow in suspension

Method for processing and preserving collagen-based tissues for transplantation

Drying process

Immunogenic composition

Vaccine against Streptococcus pneumoniae

Advanced oral poliovirus vaccine (Adv-OPV) deprived of the possibility of vaccine associated paralytic poliomyelities (VAPP)

Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein

Bacterial vectors and methods of use thereof

Chimeric lyssavirus nucleic acids and polypeptides